Home Cart 0 Sign in  

[ CAS No. 398495-65-3 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 398495-65-3
Chemical Structure| 398495-65-3
Structure of 398495-65-3 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 398495-65-3 ]

Related Doc. of [ 398495-65-3 ]

Alternatived Products of [ 398495-65-3 ]

Product Details of [ 398495-65-3 ]

CAS No. :398495-65-3 MDL No. :MFCD08061258
Formula : C13H20N4O4 Boiling Point : -
Linear Structure Formula :- InChI Key :VUWAGENLXQIUJY-UHFFFAOYSA-N
M.W : 296.32 Pubchem ID :6919045
Synonyms :

Calculated chemistry of [ 398495-65-3 ]

Physicochemical Properties

Num. heavy atoms : 21
Num. arom. heavy atoms : 5
Fraction Csp3 : 0.62
Num. rotatable bonds : 6
Num. H-bond acceptors : 5.0
Num. H-bond donors : 1.0
Molar Refractivity : 79.56
TPSA : 99.68 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : No
P-gp substrate : Yes
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -7.52 cm/s

Lipophilicity

Log Po/w (iLOGP) : 2.76
Log Po/w (XLOGP3) : 0.83
Log Po/w (WLOGP) : 1.04
Log Po/w (MLOGP) : 1.11
Log Po/w (SILICOS-IT) : -0.22
Consensus Log Po/w : 1.11

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -1.98
Solubility : 3.1 mg/ml ; 0.0105 mol/l
Class : Very soluble
Log S (Ali) : -2.51
Solubility : 0.925 mg/ml ; 0.00312 mol/l
Class : Soluble
Log S (SILICOS-IT) : -1.31
Solubility : 14.5 mg/ml ; 0.0489 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 1.0 alert
Leadlikeness : 0.0
Synthetic accessibility : 3.19

Safety of [ 398495-65-3 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 398495-65-3 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 398495-65-3 ]
  • Downstream synthetic route of [ 398495-65-3 ]

[ 398495-65-3 ] Synthesis Path-Upstream   1~8

  • 1
  • [ 398491-59-3 ]
  • [ 541-41-3 ]
  • [ 398495-65-3 ]
YieldReaction ConditionsOperation in experiment
72% With N-ethyl-N,N-diisopropylamine In tetrahydrofuran at 0 - 20℃; A solution of ethyl chlorocarbonate (8.9 ml, 93 mmol) in THF (250 ml) was added slowly to a mixture of 3-amino-4, 6-dihydro-lH-pyrrolo [3, 4-C] ole-5-carboxylic acid tert-butyl ester (20 g, 89 mmol) and DIISOPROPYLETHYLAMINE (DIEA, 92 ml, 528 mmol) in THF (500 ml) at 0-5°C. The reaction was kept at the same temperature for two hours then allowed to reach room temperature and stirred overnight. The obtained mixture was evaporated to dryness under vacuum. The resulting residue was extracted with ethyl acetate and water. The organic phase was separated, dried over sodium sulfate and evaporated to dryness. The mixture was purified by flash-chromatography (eluent : ethyl ACETATE/EYCLOHEXANE 4/6 to 7/3) to give 19 g (72percent yield) of the title compound as a white solid. 1H-NMR (400 MHZ, DMSO-S6) ppm: 10. 06 (S, broad signal, 2H), 4. 4-4. 05 (M, 6H), 1.27 (t, 3H) 1 (2, 9H).
72% With N-ethyl-N,N-diisopropylamine In tetrahydrofuran EXAMPLE 27
Preparation of 3-Amino-4,6-dihydro-pyrrolo[3,4-c]pyrazole-1,5-dicarboxylic acid 5-tert-butyl ester 1-ethyl ester
A solution of ethyl chlorocarbonate (8.9 ml, 93 mmol) in THF (250 ml) was added slowly to a mixture of 3-amino-4,6-dihydro-1H-pyrrolo[3,4-c]pyrazole-5-carboxylic acid tert-butyl ester (20 g, 89 mmol) and DIEA (92 ml, 528 mmol) in THF (500 ml) at 0-5° C.
The reaction was kept at the same temperature for two hours then allowed to reach r.t. and stirred overnight.
The obtained mixture was evaporated to dryness under vacuum.
The resulting residue was extracted with AcOEt and water.
The organic phase was separated, dried over sodium sulfate and evaporated to dryness.
The mixture was purified by flash-chromatography (eluent: ethyl acetate/cyclohexane 4/6 to 7/3) to give 19 g (72percent yield) of the title compound as a white solid.
62% With N-ethyl-N,N-diisopropylamine In tetrahydrofuran at 0 - 20℃; for 13 h; To a solution of tert-butyl 3-cyano-4-oxopyrrolidine-1-carboxylate 1 (40.00 g, 0.18 mol) and ethyldiisopropylamine (DIEA) (138.00 g, 1.06 mol) in dry THF (700 mL) was added dropwise a solution of ethyl chlorocarbonate (20.20 g, 0.19 mol) in dry THF (250 mL) over a period of 1 h at 0-5 °C. The reaction mixture was stirred for 12 h at room temperature and concentrated under reduced pressure. The residue was treated with ethyl acetate (500 mL), washed successively with water and saturated saline, dried over anhydrous MgSO4, and filtered. The filtrate was concentrated under reduced pressure, and the crude product was recrystallized from dichloromethane / ethyl acetate /petroleum ether (40 mL: 60 mL: 160 mL) to afford the title compound 2 (32.70 g, 62percent) as a white solid, mp: 167-168 °C.
60.7% With N-ethyl-N,N-diisopropylamine In tetrahydrofuran at 0 - 20℃; Synthesis of compound 9b Ethyl chloroformate (4.5 ml, 46.5 mmol) was dissolved in tetrahydrofuran (100 ml), with ice bath, compound 8b (10 g, 44.5 mmol) and DIPEA (46 ml, 264 mmol) were dissolved in tetrahydrofuran (250 ml), at 0-5 °C add the drops into reaction solution, then rise to the room temperature for reaction of 16 hours, then vacuum evaporate the reaction solution and dissolve the residue with ethyl acetate, and wash the organic phase with water, dry the organic phase with sodium sulfate, vacuum evaporate the solvent with lower pressure, purify the residue with silica gel layer chromatography (ethyl acetate: petroleum ester=1:3), to give the white solid(compound 9b : 8.0 g, 60.7percent yield). 1H NMR (400 MHz, CD3OD) δ 4.72 (s, 2H), 4.40 (q, J=7.2Hz, 2H), 4.12 (d, J=7.2Hz, 2H), 1.53 (s, 9H), 1.40 (t, J=6.8Hz, 3H).
1.62 g With N-ethyl-N,N-diisopropylamine In tetrahydrofuran at 0 - 5℃; Step 1. 5-(tert-butyl) 1-ethyl 3-amino-4,6-dihydropyrrolo[3,4-c]pyrazole-1,5-dicarboxylate
A solution of ethyl chloroformate (0.90 ml; 0.01 mol; 1.05 eq.) in 20 ml of THF was slowly added to a mixture of tert-butyl 3-amino-1H,4H,5H,6H-pyrrolo[3,4-c]pyrazole-5-carboxylate (2.00 g; 0.01 mol; 1.00 eq.) and Hunig's base (8.81 ml; 0.05 mol; 6.00 eq.) in tetrahydrofuran (50.00 ml) at 0-5° C. The reaction was kept at the same temperature for two hours, then allowed to reach room temperature and stirred overnight. The reaction mixture was evaporated to dryness and the resulting residue was partitioned in ethyl acetate and water. The organic phase was separated and the aqueous layer was back extracted with EtOAc. The combined organics were washed with brine, dried over Na2SO4, filtered and evaporated to dryness. The crude was purified by flash-chromatography using 0-90percent EtOAc in hexanes to give the desired 5-(tert-butyl) 1-ethyl 3-amino-4,6-dihydropyrrolo[3,4-c]pyrazole-1,5-dicarboxylate (1.62 g). 1H NMR (400 MHz, DMSO-d6) δ 5.67 (d, J=2.2 Hz, 2H), 4.44 (dt, J=10.7, 3.1 Hz, 2H), 4.25 (q, J=7.1 Hz, 2H), 4.15 (dt, J=18.3, 3.2 Hz, 2H), 1.42 (s, 9H), 1.26 (td, J=7.1, 1.4 Hz, 3H). MS (M+H)+ found for C13H20N4O4: 296.5.
30 g With N-ethyl-N,N-diisopropylamine In tetrahydrofuran at 0℃; (6) 24.8 g (0.11 mol) of the general formula (16) was added to 200 mL of THF,DIEA 18.3 mL (0.11 mol) was added with stirring under ice-salt bath,And 10.5 mL (0.11 mol) of ethyl chloroformate diluted with THF was added dropwise thereto. The temperature was controlled to 0 ° C or lower,Reaction 5-6 h, TLC monitoring. Post-treatment, concentration under reduced pressure, extraction with methylene chloride,Washed with saturated NaCl, and dried over anhydrous sodium sulfate. The solvent was distilled off under reduced pressure to give the compound of formula (17) as a pale yellow solid,30.0 g.
3.2 g With N-ethyl-N,N-diisopropylamine In tetrahydrofuran at 0 - 20℃; for 2.16667 h; To a solution of tert-butyl 3-amino-4,6-dihydropyrrolo[3,4-c]pyrazole-5(lH)-carboxylate (2.600 g, 11.607 mmol) in THF (30 ml) was added DIPEA (11.8 ml, 69.6 mmol) at 0°C. Ethyl chloroformate (1.11 ml, 11.72 mmol) was added dropwise to the reaction mixture at 0°C. The reaction mixture was stirred at 0°C for 10 min and then at rt for 2 h. The reaction mixture was poured into water (60 ml) and extracted with EtOAc (3 x 60 ml). The combined organic layer was dried over Na2SO4, filtered and concentrated under reduced pressure. The residue was purified by flash chromatography (2-3percent MeOH in DCM) yielding 5-tert-butyl 1-ethyl 3-amino-4,6- dihydropyrrolo[3,4-c]pyrazole-l,5-dicarboxylate (3.200 g, 10.81 mmol). LCMS: Method 1, 1.986, MS: ES+ 297.43.

Reference: [1] Journal of Medicinal Chemistry, 2005, vol. 48, # 8, p. 3080 - 3084
[2] Bioorganic and Medicinal Chemistry Letters, 2006, vol. 16, # 4, p. 1084 - 1090
[3] Patent: WO2004/80457, 2004, A1, . Location in patent: Page/Page column 28-29
[4] Patent: US2003/171357, 2003, A1,
[5] Bioorganic and Medicinal Chemistry Letters, 2010, vol. 20, # 14, p. 4273 - 4278
[6] Bioorganic and Medicinal Chemistry Letters, 2012, vol. 22, # 22, p. 6947 - 6951,5
[7] Patent: EP3133069, 2017, A1, . Location in patent: Paragraph 0073
[8] Journal of Medicinal Chemistry, 2006, vol. 49, # 24, p. 7247 - 7251
[9] Patent: WO2005/5427, 2005, A1, . Location in patent: Page/Page column 20
[10] Patent: US2015/315198, 2015, A1, . Location in patent: Paragraph 1653; 1654
[11] Patent: CN104072498, 2016, B, . Location in patent: Paragraph 0118; 0151
[12] Patent: WO2017/158381, 2017, A1, . Location in patent: Page/Page column 57
  • 2
  • [ 25544-75-6 ]
  • [ 175463-32-8 ]
  • [ 398495-65-3 ]
YieldReaction ConditionsOperation in experiment
40.3 g at 60℃; 5) 33.1 g (0.16 mol) of the general formula (14) was added to 200 mL of anhydrous ethanol,22.4 g (0.16 mol) of ethyl hydrazinecarboxylate hydrochloride was added in portions, and the reaction was carried out at 60 ° C for 4 to 5 hours. The reaction was monitored by TLC.The filtrate was concentrated under reduced pressure to give 40.3 g of a white solid of general formula (17).
Reference: [1] Patent: CN104072498, 2016, B, . Location in patent: Paragraph 0087
  • 3
  • [ 3088-42-4 ]
  • [ 398495-65-3 ]
Reference: [1] Journal of Medicinal Chemistry, 2005, vol. 48, # 8, p. 3080 - 3084
[2] Patent: CN104072498, 2016, B,
[3] Patent: CN104072498, 2016, B,
[4] Patent: CN104072498, 2016, B,
  • 4
  • [ 175463-32-8 ]
  • [ 398495-65-3 ]
Reference: [1] Journal of Medicinal Chemistry, 2005, vol. 48, # 8, p. 3080 - 3084
[2] Patent: CN104072498, 2016, B,
[3] Patent: WO2017/158381, 2017, A1,
  • 5
  • [ 266353-19-9 ]
  • [ 398495-65-3 ]
Reference: [1] Journal of Medicinal Chemistry, 2005, vol. 48, # 8, p. 3080 - 3084
  • 6
  • [ 44915-39-1 ]
  • [ 398495-65-3 ]
Reference: [1] Journal of Medicinal Chemistry, 2005, vol. 48, # 8, p. 3080 - 3084
  • 7
  • [ 266353-18-8 ]
  • [ 398495-65-3 ]
Reference: [1] Patent: CN104072498, 2016, B,
[2] Patent: CN104072498, 2016, B,
[3] Patent: CN104072498, 2016, B,
  • 8
  • [ 44981-94-4 ]
  • [ 398495-65-3 ]
Reference: [1] Patent: CN104072498, 2016, B,
[2] Patent: CN104072498, 2016, B,
[3] Patent: CN104072498, 2016, B,
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 398495-65-3 ]

Amides

Chemical Structure| 398491-59-3

[ 398491-59-3 ]

tert-Butyl 3-amino-4,6-dihydropyrrolo[3,4-c]pyrazole-5(1H)-carboxylate

Similarity: 0.86

Chemical Structure| 1204298-58-7

[ 1204298-58-7 ]

tert-Butyl 3-amino-1H-indazole-1-carboxylate

Similarity: 0.85

Chemical Structure| 398491-61-7

[ 398491-61-7 ]

tert-Butyl 3-amino-6,6-dimethylpyrrolo[3,4-c]pyrazole-5(1H,4H,6H)-carboxylate

Similarity: 0.79

Chemical Structure| 657428-42-7

[ 657428-42-7 ]

tert-Butyl 4,6-dihydropyrrolo[3,4-c]pyrazole-5(1H)-carboxylate

Similarity: 0.78

Chemical Structure| 219503-81-8

[ 219503-81-8 ]

tert-Butyl 6-amino-1H-indazole-1-carboxylate

Similarity: 0.76

Amines

Chemical Structure| 398491-59-3

[ 398491-59-3 ]

tert-Butyl 3-amino-4,6-dihydropyrrolo[3,4-c]pyrazole-5(1H)-carboxylate

Similarity: 0.86

Chemical Structure| 1204298-58-7

[ 1204298-58-7 ]

tert-Butyl 3-amino-1H-indazole-1-carboxylate

Similarity: 0.85

Chemical Structure| 398491-61-7

[ 398491-61-7 ]

tert-Butyl 3-amino-6,6-dimethylpyrrolo[3,4-c]pyrazole-5(1H,4H,6H)-carboxylate

Similarity: 0.79

Chemical Structure| 219503-81-8

[ 219503-81-8 ]

tert-Butyl 6-amino-1H-indazole-1-carboxylate

Similarity: 0.76

Chemical Structure| 129488-10-4

[ 129488-10-4 ]

tert-Butyl 5-amino-1H-indazole-1-carboxylate

Similarity: 0.75

Related Parent Nucleus of
[ 398495-65-3 ]

Other Aromatic Heterocycles

Chemical Structure| 398491-59-3

[ 398491-59-3 ]

tert-Butyl 3-amino-4,6-dihydropyrrolo[3,4-c]pyrazole-5(1H)-carboxylate

Similarity: 0.86

Chemical Structure| 398491-61-7

[ 398491-61-7 ]

tert-Butyl 3-amino-6,6-dimethylpyrrolo[3,4-c]pyrazole-5(1H,4H,6H)-carboxylate

Similarity: 0.79

Chemical Structure| 657428-42-7

[ 657428-42-7 ]

tert-Butyl 4,6-dihydropyrrolo[3,4-c]pyrazole-5(1H)-carboxylate

Similarity: 0.78

Chemical Structure| 230301-11-8

[ 230301-11-8 ]

tert-Butyl 6,7-dihydro-1H-pyrazolo[4,3-c]pyridine-5(4H)-carboxylate

Similarity: 0.71

Chemical Structure| 1196154-25-2

[ 1196154-25-2 ]

tert-Butyl 3-bromo-6,7-dihydropyrazolo[1,5-a]pyrazine-5(4H)-carboxylate

Similarity: 0.67